Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,937
Closed -$220K 76
2024
Q3
$220K Hold
1,937
0.13% 71
2024
Q2
$240K Hold
1,937
0.15% 64
2024
Q1
$256K Sell
1,937
-76
-4% -$9.37K 0.17% 57
2023
Q4
$219K Sell
2,013
-958
-32% -$99.4K 0.16% 52
2023
Q3
$306K Hold
2,971
0.25% 43
2023
Q2
$343K Sell
2,971
-406
-12% -$46.1K 0.29% 40
2023
Q1
$359K Hold
3,377
0.32% 34
2022
Q4
$375K Hold
3,377
0.33% 35
2022
Q3
$291K Hold
3,377
0.26% 37
2022
Q2
$308K Sell
3,377
-12
-0.4% -$1.06K 0.27% 41
2022
Q1
$278K Buy
+3,389
New +$267K 0.29% 42

Other funds holding MRK

MTM Financial Group's MRK Position: Q4 2024 in Review

MTM Financial Group sold out of Merck (MRK) in Q4 2024, closing a stake of 1,937 shares — an estimated $220K sold.

MTM Financial Group first reported a position in MRK in Q1 2022 and held it in 11 quarters. The position peaked at $375K in Q4 2022. 3,612 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • MTM Financial Group reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • MTM Financial Group sold 1,937 Merck shares in Q4 2024, an estimated $220K.
  • MTM Financial Group first reported a position in Merck in Q1 2022 and held it in 11 quarters.
  • MTM Financial Group's Merck position peaked at $375K in Q4 2022.
  • 3,612 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on MTM Financial Group's 13F filing for Q4 2024, filed 23 Jun 2026.